Research & Development Overview

NeoStem, a leader in the emerging field of cell therapy, has a multi-pronged research and clinical development strategy, featuring three proprietary cell therapeutics at different stages of development. We invite you to learn more about our cell therapeutics, stem cell research, and future development of these technologies by clicking through our website.


Amorcyte_Logo2_sm

Enhancing the body’s healing response
NeoStem is developing AMR-001, NeoStem’s most clinically advanced therapeutic, a cell therapy for the treatment of cardiovascular disease.

Learn More


AthelosLogo_sm

Rebalancing the immune system
NeoStem is in early stage clinical development of a T-cell therapy for autoimmune and inflammatory conditions.

Learn More


VSEL_sm

Discovering the incredible power of VSELsTM
NeoStem is engaged in research and development of new therapies based on very small embryonic-like stem cells (VSELTM Technology).

Learn More

NeoStem - Cell Therapy Development - Clinical